METHOD FOR COMBINATION THERAPY FOR ROSACEA OF ERITHEMATOUS-TELEANGECTATIC SUBTYPE Russian patent published in 2022 - IPC A61N5/06 A61K31/498 A61P17/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to dermatology and cosmetology, and can be used for the treatment of rosacea of ​​the erythematous-telangectatic subtype. Then 0.5% brimonidine tartrate gel is applied to the affected skin daily, once a day, in the morning, for 3 months. The drug is applied to the affected areas: forehead, cheeks, nose and chin. Procedures of broadband pulsed light radiation with a wavelength range of 500-1200 nm are carried out on a multi-module platform M22 using an IPL (Intensive pulse light) nozzle, and the procedures are carried out 1 time in 28-30 days, a course of 3 procedures. After the procedure is completed, patients are applied photoprotectors with a protection factor of 50 to the affected areas.

EFFECT: method provides an increase in the period of remission, reduces the duration of treatment and reduces the likelihood of side effects due to the combination of broadband pulsed light radiation with topical application of brimonidine tartrate.

1 cl, 3 dwg, 1 tbl, 3 ex